Xenon Pharmaceuticals Inc. (XENE)
NASDAQ: XENE · Real-Time Price · USD
40.17
+0.97 (2.47%)
Jan 2, 2025, 4:00 PM EST - Market closed
Xenon Pharmaceuticals Employees
As of December 31, 2023, Xenon Pharmaceuticals had 259 total employees, including 251 full-time and 8 part-time employees. The number of employees increased by 46 or 21.60% compared to the previous year.
Employees
259
Change (1Y)
46
Growth (1Y)
21.60%
Revenue / Employee
n/a
Profits / Employee
-$823,892
Market Cap
3.06B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
XENE News
- 27 days ago - Xenon Showcases New Long-Term Azetukalner Data from X-TOLE OLE Study in FOS at AES 2024 - GlobeNewsWire
- 5 weeks ago - Xenon to Showcase New Long-Term Azetukalner Data at AES 2024 - GlobeNewsWire
- 7 weeks ago - Xenon to Present at Upcoming Investor Conferences - GlobeNewsWire
- 7 weeks ago - Xenon Pharmaceuticals Inc. (XENE) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Xenon Reports Q3 2024 Financial Results and Business Update - GlobeNewsWire
- 2 months ago - Xenon to Report Q3 2024 Financial Results on November 12, 2024 - GlobeNewsWire
- 3 months ago - Xenon to Present at BofA Securities 2024 CNS Therapeutics Virtual Conference - GlobeNewsWire
- 4 months ago - Xenon Showcases Azetukalner Data at 15th European Epilepsy Congress - GlobeNewsWire